Статті в журналах з теми "M. smegmatis - Rifampicin"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-38 статей у журналах для дослідження на тему "M. smegmatis - Rifampicin".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Do, Thi Thuy, Jerónimo Rodríguez-Beltran, Esmeralda Cebrián-Sastre, Alexandro Rodríguez-Rojas, Alfredo Castañeda-García, and Jesús Blázquez. "Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis." Antibiotics 11, no. 4 (April 12, 2022): 509. http://dx.doi.org/10.3390/antibiotics11040509.
Повний текст джерелаDey, Abhinav, Amit Kumar Verma, and Dipankar Chatterji. "Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin." Microbiology 156, no. 3 (March 1, 2010): 873–83. http://dx.doi.org/10.1099/mic.0.033670-0.
Повний текст джерелаKurthkoti, Krishna, Thiruneelakantan Srinath, Pradeep Kumar, Vidyasagar S. Malshetty, Pau Biak Sang, Ruchi Jain, Ramanathapuram Manjunath, and Umesh Varshney. "A distinct physiological role of MutY in mutation prevention in mycobacteria." Microbiology 156, no. 1 (January 1, 2010): 88–93. http://dx.doi.org/10.1099/mic.0.033621-0.
Повний текст джерелаTran, Huyen Thi, Julia Solnier, Eva-Maria Pferschy-Wenzig, Olaf Kunert, Liam Martin, Sanjib Bhakta, Loi Huynh, Tri Minh Le, Rudolf Bauer, and Franz Bucar. "Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria." Antibiotics 9, no. 7 (July 8, 2020): 390. http://dx.doi.org/10.3390/antibiotics9070390.
Повний текст джерелаVerma, Amit Kumar, and Dipankar Chatterji. "Dual role of MsRbpA: transcription activation and rescue of transcription from the inhibitory effect of rifampicin." Microbiology 160, no. 9 (September 1, 2014): 2018–29. http://dx.doi.org/10.1099/mic.0.079186-0.
Повний текст джерелаSolnier, Julia, Liam Martin, Sanjib Bhakta, and Franz Bucar. "Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species." Molecules 25, no. 3 (February 7, 2020): 734. http://dx.doi.org/10.3390/molecules25030734.
Повний текст джерелаSachan, Tarun Kumar, and Virendra Kumar. "Antibiotic Susceptibility in Biofilms of Mycobacterium smegmatis." International Journal of Applied Sciences and Biotechnology 3, no. 4 (December 30, 2015): 635–41. http://dx.doi.org/10.3126/ijasbt.v3i4.13522.
Повний текст джерелаTamuhla, Tsaone, Lydia Joubert, Danicke Willemse, and Monique J. Williams. "SufT is required for growth of Mycobacterium smegmatis under iron limiting conditions." Microbiology 166, no. 3 (March 1, 2020): 296–305. http://dx.doi.org/10.1099/mic.0.000881.
Повний текст джерелаKunota, Tafara T. R., Md Aejazur Rahman, Barry E. Truebody, Jared S. Mackenzie, Vikram Saini, Dirk A. Lamprecht, John H. Adamson, et al. "Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility." Antioxidants 10, no. 8 (August 13, 2021): 1285. http://dx.doi.org/10.3390/antiox10081285.
Повний текст джерелаMalshetty, Vidyasagar, Krishna Kurthkoti, Arnab China, Bratati Mallick, Subburaj Yamunadevi, Pau Biak Sang, Narayanaswamy Srinivasan, Valakunja Nagaraja, and Umesh Varshney. "Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription." Microbiology 156, no. 5 (May 1, 2010): 1565–73. http://dx.doi.org/10.1099/mic.0.036970-0.
Повний текст джерелаChandra, Harish, Seemi Farhat Basir, Manish Gupta, and Nirupama Banerjee. "Glutamine synthetase encoded by glnA-1 is necessary for cell wall resistance and pathogenicity of Mycobacterium bovis." Microbiology 156, no. 12 (December 1, 2010): 3669–77. http://dx.doi.org/10.1099/mic.0.043828-0.
Повний текст джерелаStrharsky, Tomas, Dominika Pindjakova, Jiri Kos, Lucia Vrablova, Hana Michnova, Jan Hosek, Nicol Strakova, et al. "Study of Biological Activities and ADMET-Related Properties of Novel Chlorinated N-arylcinnamamides." International Journal of Molecular Sciences 23, no. 6 (March 15, 2022): 3159. http://dx.doi.org/10.3390/ijms23063159.
Повний текст джерелаObakiro, Samuel Baker, Ambrose Kiprop, Isaac K’owino, Moses Andima, Richard Oriko Owor, Robi Chacha, and Elizabeth Kigondu. "Phytochemical, Cytotoxicity, and Antimycobacterial Activity Evaluation of Extracts and Compounds from the Stem Bark of Albizia coriaria Welw ex. Oliver." Evidence-Based Complementary and Alternative Medicine 2022 (January 22, 2022): 1–20. http://dx.doi.org/10.1155/2022/7148511.
Повний текст джерелаKisiel-Nawrot, Ewa, Dominika Pindjakova, Malgorzata Latocha, Andrzej Bak, Violetta Kozik, Kinga Suwinska, Aleksander Sochanik, Alois Cizek, Josef Jampilek, and Andrzej Zięba. "Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives." International Journal of Molecular Sciences 23, no. 23 (December 1, 2022): 15078. http://dx.doi.org/10.3390/ijms232315078.
Повний текст джерелаAlexander, David C., Joses R. W. Jones, and Jun Liu. "A Rifampin-Hypersensitive Mutant Reveals Differences between Strains of Mycobacterium smegmatis and Presence of a Novel Transposon, IS1623." Antimicrobial Agents and Chemotherapy 47, no. 10 (October 2003): 3208–13. http://dx.doi.org/10.1128/aac.47.10.3208-3213.2003.
Повний текст джерелаKarunakaran, Ponniah, and Julian Davies. "Genetic Antagonism and Hypermutability inMycobacterium smegmatis." Journal of Bacteriology 182, no. 12 (June 15, 2000): 3331–35. http://dx.doi.org/10.1128/jb.182.12.3331-3335.2000.
Повний текст джерелаQuan, S., H. Venter, and E. R. Dabbs. "Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic." Antimicrobial Agents and Chemotherapy 41, no. 11 (November 1997): 2456–60. http://dx.doi.org/10.1128/aac.41.11.2456.
Повний текст джерелаMcDermott, Patrick F., David G. White, Isabelle Podglajen, Michael N. Alekshun, and Stuart B. Levy. "Multidrug Resistance following Expression of the Escherichia coli marA Gene in Mycobacterium smegmatis." Journal of Bacteriology 180, no. 11 (June 1, 1998): 2995–98. http://dx.doi.org/10.1128/jb.180.11.2995-2998.1998.
Повний текст джерелаMan, DeDe Kwun-Wai, Tokuwa Kanno, Giorgia Manzo, Brian D. Robertson, Jenny K. W. Lam, and A. James Mason. "Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides." mSphere 3, no. 4 (July 18, 2018): e00218-18. http://dx.doi.org/10.1128/msphere.00218-18.
Повний текст джерелаStephan, Joachim, Claudia Mailaender, Gilles Etienne, Mamadou Daffé, and Michael Niederweis. "Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis." Antimicrobial Agents and Chemotherapy 48, no. 11 (November 2004): 4163–70. http://dx.doi.org/10.1128/aac.48.11.4163-4170.2004.
Повний текст джерелаRen, Huiping, and Jun Liu. "AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs." Antimicrobial Agents and Chemotherapy 50, no. 1 (January 2006): 250–55. http://dx.doi.org/10.1128/aac.50.1.250-255.2006.
Повний текст джерелаDhouib, Rabeb, Françoise Laval, Frédéric Carrière, Mamadou Daffé, and Stéphane Canaan. "A Monoacylglycerol Lipase from Mycobacterium smegmatis Involved in Bacterial Cell Interaction." Journal of Bacteriology 192, no. 18 (July 2, 2010): 4776–85. http://dx.doi.org/10.1128/jb.00261-10.
Повний текст джерелаNaas, Thierry, Yuzuru Mikami, Tamae Imai, Laurent Poirel, and Patrice Nordmann. "Characterization of In53, a Class 1 Plasmid- and Composite Transposon-Located Integron of Escherichia coli Which Carries an Unusual Array of Gene Cassettes." Journal of Bacteriology 183, no. 1 (January 1, 2001): 235–49. http://dx.doi.org/10.1128/jb.183.1.235-249.2001.
Повний текст джерелаKana, Bavesh D., Garth L. Abrahams, Nackmoon Sung, Digby F. Warner, Bhavna G. Gordhan, Edith E. Machowski, Liana Tsenova, et al. "Role of the DinB Homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis." Journal of Bacteriology 192, no. 8 (February 5, 2010): 2220–27. http://dx.doi.org/10.1128/jb.01135-09.
Повний текст джерелаPaul, Avraneel, Rashmi Ravindran Nair, Kishor Jakkala, Atul Pradhan, and Parthasarathi Ajitkumar. "Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics." Antimicrobial Agents and Chemotherapy, April 18, 2022. http://dx.doi.org/10.1128/aac.02285-21.
Повний текст джерелаPradhan, Suchitra, Shwetha K., Pratibha Kumari, and Ravi Kumar. "Biochemical and functional characterization of the SMC holocomplex from Mycobacterium smegmatis." Microbiology, December 22, 2020. http://dx.doi.org/10.1099/mic.0.001011.
Повний текст джерелаGiddey, Alexander D., Tariq A. Ganief, Naadir Ganief, Anastasia Koch, Digby F. Warner, Nelson C. Soares, and Jonathan M. Blackburn. "Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure." Frontiers in Medicine 8 (October 5, 2021). http://dx.doi.org/10.3389/fmed.2021.723667.
Повний текст джерелаGiddey, Alexander D., Tariq A. Ganief, Naadir Ganief, Anastasia Koch, Digby F. Warner, Nelson C. Soares, and Jonathan M. Blackburn. "Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure." Frontiers in Medicine 8 (October 5, 2021). http://dx.doi.org/10.3389/fmed.2021.723667.
Повний текст джерелаFaulkner, Valwynne, Adrienne Adele Cox, Shan Goh, Annelies van Bohemen, Amanda J. Gibson, Oliver Liebster, Brendan W. Wren, Sam Willcocks, and Sharon L. Kendall. "Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits." Frontiers in Microbiology 11 (February 1, 2021). http://dx.doi.org/10.3389/fmicb.2020.619427.
Повний текст джерелаRai, Deepika, and Sarika Mehra. "The mycobacterial efflux pump EfpA can induce high drug tolerance to many anti-tuberculosis drugs, including moxifloxacin, in Mycobacterium smegmatis." Antimicrobial Agents and Chemotherapy, August 23, 2021. http://dx.doi.org/10.1128/aac.00262-21.
Повний текст джерелаDe Siena, Barbara, Nicoletta Campolattano, Gianluca D’Abrosca, Luigi Russo, Daire Cantillon, Rosangela Marasco, Lidia Muscariello, Simon J. Waddell, and Margherita Sacco. "Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux." Frontiers in Microbiology 11 (December 3, 2020). http://dx.doi.org/10.3389/fmicb.2020.575828.
Повний текст джерелаJakkala, Kishor, Avraneel Paul, Atul Pradhan, Rashmi Ravindran Nair, Deepti Sharan, Sharmada Swaminath, and Parthasarathi Ajitkumar. "Unique Mode of Cell Division by the Mycobacterial Genetic Resister Clones Emerging De Novo from the Antibiotic-Surviving Population." mSphere 5, no. 6 (November 18, 2020). http://dx.doi.org/10.1128/msphere.00994-20.
Повний текст джерелаPradhan, Atul, Sharmada Swaminath, Kishor Jakkala, and Parthasarathi Ajitkumar. "A method for the enrichment, isolation and validation of Mycobacterium smegmatis population surviving in the presence of bactericidal concentrations of rifampicin and moxifloxacin." FEMS Microbiology Letters 368, no. 14 (July 2021). http://dx.doi.org/10.1093/femsle/fnab090.
Повний текст джерелаShen, Hongbo, Feifei Wang, Gucheng Zeng, Ling Shen, Han Cheng, Dan Huang, Richard Wang, Lijun Rong, and Zheng W. Chen. "Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice." Scientific Reports 6, no. 1 (September 7, 2016). http://dx.doi.org/10.1038/srep32725.
Повний текст джерелаKalapala, Yeswanth Chakravarthy, Pallavi Raj Sharma, and Rachit Agarwal. "Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions." Frontiers in Microbiology 11 (December 14, 2020). http://dx.doi.org/10.3389/fmicb.2020.583661.
Повний текст джерелаMaeda, Tomoya, Masako Kawada, Natsue Sakata, Hazuki Kotani, and Chikara Furusawa. "Laboratory evolution of Mycobacterium on agar plates for analysis of resistance acquisition and drug sensitivity profiles." Scientific Reports 11, no. 1 (July 23, 2021). http://dx.doi.org/10.1038/s41598-021-94645-z.
Повний текст джерелаFishbein, Skye R. S., Francesca G. Tomasi, Ian D. Wolf, Charles L. Dulberger, Albert Wang, Hasmik Keshishian, Luke Wallace, et al. "The conserved translation factor LepA is required for optimal synthesis of a porin family in Mycobacterium smegmatis." Journal of Bacteriology, December 23, 2020. http://dx.doi.org/10.1128/jb.00604-20.
Повний текст джерелаEaland, Christopher, Binayak Rimal, James Chang, Lethabo Mashigo, Melissa Chengalroyen, Lusanda Mapela, Germar Beukes, Edith Machowski, Sung Joon Kim, and Bavesh Kana. "Resuscitation-Promoting Factors Are Required for Mycobacterium smegmatis Biofilm Formation." Applied and Environmental Microbiology 84, no. 17 (June 18, 2018). http://dx.doi.org/10.1128/aem.00687-18.
Повний текст джерела